Bank Of America Corp Bellerophon Therapeutics, Inc. Transaction History

Bank Of America Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$1.82 - $3.24 $85 - $152	-47 Reduced 52.22%	43 $0
Q4 2021 Feb 08, 2022	BUY	$2.36 - $4.05 $37 - $64	16 Added 21.62%	90 $0
Q3 2021 Nov 15, 2021	SELL	$3.75 - $4.86 $2,497 - $3,236	-666 Reduced 90.0%	74 $0
Q2 2021 Sep 13, 2021	BUY	$3.83 - $5.65 $2,834 - $4,181	740 New	740 $4,000

44K

Ticker BLPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,545,450
Market Cap $382K
Description
Bellerophon Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development of products for the treatment of cardiopulmonary diseases in the United States. Its product includes INOpulse, a proprietary pulsatile nitric oxide delivery platform for the treatment of pulmonary hypertension. The company engages in the development...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.